ImmuCell.jpg
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024
August 13, 2024 16:05 ET | ImmuCell Corporation
PORTLAND, Maine, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell.jpg
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024
August 07, 2024 16:05 ET | ImmuCell Corporation
PORTLAND, Maine, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell.jpg
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024
July 09, 2024 16:05 ET | ImmuCell Corporation
PORTLAND, Maine, July 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
Acri Capital Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
June 12, 2024 16:00 ET | Acri Capital Acquisition Corporation
Austin, Texas, June 12, 2024 (GLOBE NEWSWIRE) -- Acri Capital Acquisition Corporation (the “Company”) (Nasdaq: ACAC), a special purpose acquisition company, today announced that, in order to extend...
ImmuCell.jpg
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®
June 05, 2024 16:05 ET | ImmuCell Corporation
PORTLAND, Maine , June 05, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell.jpg
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
June 04, 2024 16:05 ET | ImmuCell Corporation
PORTLAND, Maine, June 04, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell.jpg
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024
May 14, 2024 16:05 ET | ImmuCell Corporation
PORTLAND, Maine, May 14, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell.jpg
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024
May 08, 2024 13:00 ET | ImmuCell Corporation
PORTLAND, Maine, May 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
Acri Capital Acquisition Corporation Announces Confidential Submission of Draft Registration Statement on Form S-4 and Extension of the Deadline for an Initial Business Combination
April 10, 2024 16:30 ET | Acri Capital Acquisition Corporation
Austin, Texas, April 10, 2024 (GLOBE NEWSWIRE) -- Acri Capital Acquisition Corporation (the “Company”) (Nasdaq: ACAC), a special purpose acquisition company, today announced that, in relation to its...
ImmuCell.jpg
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
April 09, 2024 16:05 ET | ImmuCell Corporation
PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...